NEW YORK (GenomeWeb) – Era7 Bioinformatics today announced a $400,000 investment in the firm by Comercial Rafer to help accelerate the international expansion of the company.
Era7, which is based in Spain, said that it specifically wants to expand its operations in the US, where it has a subsidiary headquartered in Cambridge, Mass. It and Comercial Rafer have also reached a distribution agreement for Era7's services covering Spain and Portugal, Era7 CEO Eduardo Pareja said in a statement.
Era7 provides services focused on next-generation sequencing and bioinformatics for bacterial genomics and metagenomics. Comercial Rafer, also based in Spain, helps clinical and industrial R&D firms commercialize reagents and instruments.